Low carbohydrate diet score and odds of neuromyelitis optica spectrum disorder: A case-control study
Abstract
Abstract.Introduction: Neuromyelitis optica spectrum disorder (NMOSD) is a demyelinating inflammatory disease of The Central nervous system. We aimed to investigate the association between low carbohydrate diet (LCD) and NMOSD odds. Method: Seventy NMOSD patients with definite diagnosis and 164 hospital-based controls were enrolled in this case-control study. Dietary data was obtained using a validated 168-item food frequency questionnaire. To determine the LCD score, participants were stratified into 11 groups according to carbohydrate, protein, fat, animal fat, animal protein, vegetable fat and vegetable protein intakes. Higher intake of protein and fat, and lower intake of carbohydrate received a higher score between 0-10. Macronutrients scores were summed together and LCD scores calculated. The association between LCD scores and likelihood of being assigned to NMOSD group was investigated using multiple regression models. Results: Total LCD scores increased from the median of 21.00 in the first decile to 53.00 in the tenth decile of LCD score. After adjustment for confounding factors including age, gender, BMI, energy intake, cigarette smoking and alcohol consumption, an inverse association was detected between LCD scores and odds of NMOSD. The odds of suffering from NMOSD declined significantly about 78% (OR: 0.22; 95% CI: 0.05–0.87) and 76% (OR: 0.24; 95% CI: 0.06–0.93) in the fifth and sixth deciles of LCD score compared to the first decile. Conclusion: From the obtained results it can be speculated that higher carbohydrate and lower protein and fat intakes may be associate with the increased odds of NMOSD. However, further studies are needed to confirm these results.
References
1 . Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease. Arch Neurol. 2009;66(8):964–6.
2 . Experimental mouse model of optic neuritis with inflammatory demyelination produced by passive transfer of neuromyelitis optica-immunoglobulin G. J Neuroinflammation. 2014;11(1):16.
3 . A descriptive study of prevalence, clinical features and other findings of neuromyelitis optica and neuromyelitis optica spectrum disorder in Khuzestan Province, Iran. Iran J Neurol. 2015;14(4):204.
4 . Neuromyelitis optica: Concepts in evolution. J Neuroimmunol. 2011;231(1):100–4.
5 . The incidence and prevalence of neuromyelitis optica: A systematic review. Int J MS Care. 2013;15(3):113–8.
6 Environmental risk factors in neuromyelitis optica spectrum disorder: A case–control study. Acta Neurol Belg. 2018;118(2):1–11.
7 . Epidemiology of neuromyelitis optica spectrum disorder in Tehran, Iran: the prevalence, baseline characteristics, and clinical aspects. Neurol Sci. 2020. https://doi.org/10.1007/s10072-020-04393-7.
8 . Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica. Acta Neuropathol. 2013;126(5):699–709.
9 . Cytokines and chemokines in neuromyelitis optica: Pathogenetic and therapeutic implications. Brain Pathol. 2014;24(1):67–73.
10 Distinct serum cytokine profiles in neuromyelitis optica and multiple sclerosis. J Interferon Cytokine Res. 2013;33(2):58–64.
11 Low body mass index can be associated with the risk and poor outcomes of neuromyelitis optica with aquaporin-4 immunoglobulin G in women. J Neurol Neurosurg Psychiatry. 2018;89(11):1228–30.
12 . Sedentary lifestyle and high-carbohydrate intake are associated with low-grade chronic inflammation in post-menopause: A cross-sectional study. Rev Bras Ginecol Obstet. 2016;38(7):317–24.
13 Liver fatty acid composition and inflammation in mice fed with high-carbohydrate diet or high-fat diet. Nutrients. 2016;8(11):682.
14 . Ketogenic diet exhibits anti-inflammatory properties. Epilepsia. 2015;56:7.
15 Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation. Lipids. 2008;43(1):65–77.
16 . Advice to follow a low-carbohydrate diet has a favourable impact on low-grade inflammation in type 2 diabetes compared with advice to follow a low-fat diet. Ann Med. 2014;46(3):182–7.
17 The administration of a high refined carbohydrate diet promoted an increase in pulmonary inflammation and oxidative stress in mice exposed to cigarette smoke. Int J Chron Obstruct Pulmon Dis. 2016;11:3207.
18 . Low fat dietary intervention with ω-3 fatty acid supplementation in multiple sclerosis patients. Prostaglandins Leukot Essent Fatty Acids. 2005;73(5):397–404.
19 . Responses of inflammatory markers to a low-fat, high-carbohydrate diet: Effects of energy intake. Am J Clin Nutr. 2006;83(4):774–9.
20 Relationship of three different types of low-carbohydrate diet to cardiometabolic risk factors in a Japanese population: The INTERMAP/INTERLIPID Study. Eur J Nutr. 2016;55(4):1515–24.
21 . Low carbohydrate diet is associated with reduced risk of metabolic syndrome in Tehranian adults. Int J Food Sci Nutr. 2017;68(3):358–65.
22 . Neuroprotective and anti-inflammatory activities of ketogenic diet on MPTP-induced neurotoxicity. J Mol Neurosci. 2010;42(2):145–53.
23 . Stress management for headaches in children and adolescents: A review and practical recommendations for health promotion programs and well-being. J Child Health Care. 2018;22(1):19–33.
24 . Ketogenic diet and childhood neurological disorders other than epilepsy: An overview. Expert Rev Neurother. 2017;17(5):461–73.
25 . Ketogenic diet for the treatment of refractory epilepsy: A 10 year experience in children. Arq Neuropsiquiatr. 2007;65(2B):381–4.
26 . The ketogenic diet: Proposed mechanisms of action. Neurotherapeutics. 2009;6(2):402–5.
27 . Ketogenic dietary therapies for adults with epilepsy: Feasibility and classification of response. Epilepsy Behav. 2014;37:77–81.
28 . International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2016;86(5):491–2.
29 . Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the Tehran Lipid and Glucose Study. J Epidemiol. 2010;20(2):150–8.
30 . Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 2010;13(5):654–62.
31 Low-carbohydrate-diet score and the risk of coronary heart disease in women. N Engl J Med. 2006;355(19):1991–2002.
32 . Krause’s food & the nutrition care process. Philadelphia: Saunders; 2017.
33 . Is there a role for carbohydrate restriction in the treatment and prevention of cancer? Nutr Metab. 2011;8(1):75.
34 . Weight loss leads to reductions in inflammatory biomarkers after a very-low-carbohydrate diet and a low-fat diet in overweight men. Clin Sci. 2004;107(4):365–9.
35 . Low-carbohydrate diet review: Shifting the paradigm. Nutr Clin Pract. 2011;26(3):300–8.
36 . Dietary carbohydrates impair healthspan and promote mortality. Cell Metab. 2017;26(4):585–7.
37 . The relation of saturated fatty acids with low-grade inflammation and cardiovascular disease. J Nutr Biochem. 2016;36:1–20.
38 Low-carbohydrate nutrition and metabolism. Am J Clin Nutr. 2007;86(2):276–84.
39 . Dietary inflammatory index and risk of multiple sclerosis in a case-control study from Iran. Neuroepidemiology. 2016;47(1):26–31.
40 Interactions between dietary inflammatory index, nutritional state and Multiple Sclerosis clinical condition. Clinical Nutrition ESPEN. 2018;26:35–41.
41 . The role of diet in multiple sclerosis: A review. Nutr Neurosci. 2017;1–14.
42 Spectrum of gluten-related disorders: Consensus on new nomenclature and classification. BMC Med. 2012;10(1):13.
43 Influence of diet in multiple sclerosis: a systematic review. Adv Nutr. 2017;8(3):463–72.
44 . The evidence for dietary interventions and nutritional supplements as treatment options in multiple sclerosis: a review. Curr Treat Options Neurol. 2018;20(4):8.
45 . Mediterranean diet adherence and risk of multiple sclerosis: A case-control study. Asia Pac J Clin Nutr. 2016;25(2):377–84.
46 . Dietary pattern and risk of multiple sclerosis. Iran J Neurol. 2012;11(2):47–53.
47 . Polyunsaturated fatty acids and the risk of multiple sclerosis. Mult Scler. 2017;23(14):1830–8.
48 Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot study. Exp Biol Med. 2016;241(6):620–35.
49 . Nutritional modulation of metabolic inflammation. Biochem Soc Trans. 2017;45(4):979–85.
50 . Metabolites of dietary protein and peptides by intestinal microbes and their impacts on gut. Curr Protein Pept Sci. 2015;16(7):646–54.
